Forbes' Global2000 healthcare companies are innovating their way through the Covid-19 pandemic
“While the expected short-term impact to our financial results is significant, it is consistent with the impact discussion broadly across the medical device industry,” says Geoff Martha, Medtronic president. “Importantly, we are starting to enter the early stages of a global recovery. As hospitals begin to resume broader treatment of non-COVID-19 patients around the world, we expect our business to begin to recover as well.
For the long term, there’s a lot of promise. The global medical devices market was valued at $425.5 billion in 2018 and is expected to reach $612.7 billion by 2025, according to. Addressing the health of an aging population requires new technologies and virtual care solutions. Medtronic ranks #1 in healthcare and #129 on the Global 2000. All eyes will be on new CEO and former GE Healthcare alum, Geoff Martha who just officially stepped up to take the place of retiring Chairman & CEO and nine-year veteran Omar Ishrak. Martha vows to cut bureaucracy and drive Medtronic’s push for solutions to unmet clinical needs. For the 2020 Global 2000 list, which analyzed financial results for the twelve months ending on April 30, 2020, Medtronic recorded $31.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Study Raises Doubts Over Effectiveness Of Abbott Laboratories' Rapid Coronavirus TestIt represents a potential hindrance to ramping up testing in the United States.
Read more »
FDA Warns Abbott Coronavirus Tests Could Be InaccurateThe alert comes after an NYU study showed the company’s tests missed diagnosing up to half of known positive cases.
Read more »
Abbott Will Change Coronavirus Test Instructions for Second TimeThe change to the instructions for Abbott's fast coronavirus test device will tell users that negative results are 'presumptive' and should be verified with an alternative for patients with signs of the virus
Read more »
Abbott COVID-19 test — used by White House — could be inaccurate, FDA warnsThe test, which the FDA said could produce false negatives, got emergency use authorization in March.
Read more »
Study Raises Doubts Over Effectiveness Of Abbott Laboratories' Rapid Coronavirus TestA new study from NYU found that Abbott Laboratories' rapid coronavirus test missed diagnosing up to half of the known positive cases—signifying a major potential hindrance to ramping up testing in the U.S. by MattRyanPerez
Read more »